Home › Endometrial Cancer › Texas › Irving
Endometrial Cancer clinical trials in Irving, TX
4 studies for Endometrial Cancer are looking for participants at sites in and around Irving (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- NEXT Dallas, Irving
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
RecruitingPhase 1
- NEXT Oncology, Irving
A Study of PHST001 in Advanced Solid Tumors
RecruitingPhase 1
- NEXT Oncology - Dallas, Irving
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecruitingPhase 1
- NEXT Texas LLC - Dallas, Irving
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY53 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN37 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- San Antonio, TX27 studies
- Columbus, OH26 studies
- Chicago, IL26 studies
- Queens, NY26 studies
Other studies in Irving
- Non-Small Cell Lung Cancer22 studies
- Cancer (all types)15 studies
- Colorectal Cancer13 studies
- Metastatic Cancer11 studies
- Pancreatic Cancer7 studies
- Stomach Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Lung Cancer6 studies
- Small Cell Lung Cancer6 studies
- Breast Cancer6 studies
- Ovarian Cancer5 studies
- Triple-Negative Breast Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.